Central Glass (4044) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
18 May, 2026Executive summary
Net sales for the nine months ended December 31, 2025, were ¥104,521 million, down 0.9% year-over-year despite proactive sales efforts.
Operating profit declined 24.9% to ¥6,333 million, and profit attributable to owners of parent fell 16.2% to ¥5,756 million year-over-year.
Comprehensive income rose 23.7% to ¥8,537 million, reflecting improved other comprehensive income.
Segment reorganization implemented, now reporting four segments: Electronic Materials, Energy Materials, Life & Healthcare, and Glass.
Financial highlights
Gross profit decreased to ¥27,744 million from ¥29,971 million year-over-year.
Basic earnings per share for the nine months was ¥232.23, down from ¥277.21 year-over-year.
Equity ratio improved to 58.8% as of December 31, 2025, up from 57.0% at the previous fiscal year-end.
Dividend forecast maintained at ¥170 per share for the full year.
Outlook and guidance
Full-year net sales forecast at ¥143,200 million, up 0.7% year-over-year.
Operating profit projected at ¥8,100 million (down 23.8%), ordinary profit at ¥9,300 million (down 23.6%), and profit attributable to owners of parent at ¥6,300 million (up 10.9%).
Earnings per share forecasted at ¥254.15 for the full year.
Financial forecast revised during the period.
Latest events from Central Glass
- Operating profit and EPS rose despite lower sales; full-year outlook remains cautious.4044
Q1 202418 May 2026 - Profits and sales fell sharply, prompting a downward revision of the full-year outlook.4044
Q3 202418 May 2026 - Sales and profits fell sharply, but operating cash flow and equity ratio improved.4044
Q2 202418 May 2026 - Profits fell sharply on lower sales, but dividends are maintained amid market uncertainty.4044
Q4 202418 May 2026 - Profits fell sharply on lower sales and a major subsidiary sale will trigger an extraordinary loss.4044
Q1 202518 May 2026 - Operating profit fell 47.3% year-over-year amid lower sales and segment restructuring.4044
Q2 202518 May 2026 - Profit surged on stable sales, but cost pressures and segment shifts shape a cautious outlook.4044
Q4 202518 May 2026